DJ Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ shed 2.99% to $436.95 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.24% to 7,408.50 and Dow Jones Industrial Average falling 1.07% to 49,526.17.
This was the stock's second consecutive day of losses.
Vertex Pharmaceuticals Inc. closed 13.97% below its 52-week high of $507.92, which the company achieved on March 10th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as AbbVie Inc. $(ABBV)$ fell 0.18% to $210.39, Krystal Biotech Inc. (KRYS) fell 3.16% to $306.29, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ fell 4.60% to $7.47.
Trading volume (1.2 M) remained 46,587 below its 50-day average volume of 1.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 15, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 15, 2026 16:37 ET (20:37 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.